As of today, around 70 percent of critical Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) are imported. The PLlscheme is meant for promotion of domestic manufacturing of critical KSMs, Drug intermediates and APIs in India
The last year has been a whirl¬wind for the entire world, courtesy of the COVID-19 pan¬demic. With markets plummeting, businesses shutting down and indi¬viduals scampering to keep them¬selves safe, there has been a drastic change in industries
I ndia sees more than a million cases of cancer every year. While, countless efforts are being made all over the world to find a cure for this life-threating disease, we believe Precision Oncology can be the game changer in this direction.
A ttributing to increase in changing lifestyle, people of¬ten miss out on taking care of their health as a result of which there is an exponential increase of non-communicable diseases among the middle-aged population in the last decade.
Owing to the massive supply chain disruption and exponential cost hike of raw materials, the pharmaceutical industry is undergoing huge changes.
, CDSCO.jpg)
